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Abstract 31 
 32 
Probiotic and glutamine supplementation increases tissue Hsp72, but their influence on extracellular 33 
Hsp72 (eHsp72) has not been investigated. The aim of this study was to investigate the effect of 34 
chronic probiotic supplementation, with or without glutamine, on eHsp72 concentration before and 35 
after an ultramarathon. Thirty-two participants were split into three independent groups, where they 36 
ingested probiotic capsules (PRO, n = 11), probiotic + glutamine powder (PGLn, n = 10) or no 37 
supplementation (CON, n = 13), over a 12-week period prior to commencement of the Marathon des 38 
Sables (MDS). eHsp72 concentration in the plasma was measured at baseline, 7 days pre-race, 6-8 39 
hours post-race, and 7 days post-race. The MDS increased eHsp72 concentrations by 124% (F1,3 = 40 
22.716, p < 0.001), but there was no difference in the response between groups. Additionally, PRO or 41 
PGLn supplementation did not modify pre- or post-MDS eHsp72 concentrations compared to CON (p 42 
> 0.05). In conclusion, The MDS caused a substantial increase in eHsp72 concentration indicating high 43 
levels of systemic stress. However, chronic PRO or PGLn supplementation did not effect eHsp72 44 
compared to control pre- or post-MDS. Given the role of eHsp72 in immune activation, the 45 
commercially available supplements used in this study are unlikely to influence this cascade. 46 
 47 
Key words: Ultra-endurance; extracellular heat shock protein 72; probiotics; desert; race; event. 48 
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Introduction 61 
 62 
Exercise in extreme heat elicits physiological stress upon the human body (Nybo et al. 2001) which can 63 
decrement physical performance (Nybo et al. 2014) and cognitive function (Taylor et al. 2015). In 64 
addition, strenuous exercise coupled with high environmental temperatures (exercise heat-stress; EHS) 65 
is a major risk factor for the development of exertional heat illnesses [EHI; (Armstrong et al. 2007)]. A 66 
plethora of physiological responses including elevated core temperature (Binkley et al. 2002), 67 
increased heart rate (HR) and a redistribution of blood flow (González-Alonso et al. 2008) are seen in 68 
response to EHS (Nybo 2008; 2014). These responses initially act to protect the body from tissue 69 
damage and protein denaturation during EHS, yet they can prove catastrophic if the total stress exceeds 70 
a highly individualised threshold of tolerance [EHI; (Adams et al. 2015; Goforth et al. 2015; 71 
Wijerathne et al. 2016)]. Nonetheless, humans willingly subject themselves to prolonged EHS when 72 
completing endurance events such as the Marathon des Sables (MDS). The MDS is a 294.4 km 7 day 73 
ultra-marathon completed across the Southern Moroccan portion of Sahara Desert. Ultra-endurance 74 
events such as the MDS are becoming increasingly popular, with a substantial rise in competitor 75 
numbers in recent years (Knechtle et al. 2011; da Fonseca-Engelhardt et al. 2013). 76 
 77 
Exposure to EHS can increase extracellular heat shock protein (eHsp72) concentration (Walsh et al. 78 
2001; Whitham et al. 2007; Sandström et al. 2008; Magalhaes et al. 2010; Périard et al. 2012; Gibson et 79 
al. 2014), a protein which is thought to contribute to the immune response to EHS (Mizzen et al. 1988; 80 
Asea 2005). This increase in eHsp72 is thought to prepare the immune system (immuno-stimulatory) 81 
for subsequent EHS mediated homeostatic perturbations (Johnson et al. 2006). Although discussion 82 
regarding the precise role of eHsp72 remain (Johnson and Fleshner 2006; Whitham et al. 2008), 83 
evidence suggests that eHsp72 enhances the production of pro-inflammatory cytokines (Asea 2005) 84 
and chemokines (Lehner et al. 2000). This implies the importance of eHsp72 during EHS, given the 85 
role of pro-inflammatory cytokines in the pathophysiology of heat stroke (Lim et al. 2006; Leon et al. 86 
2010). Previous in vitro (Wischmeyer 2002; Petrof et al. 2004; Tao et al. 2006) and in vivo 87 
(Wischmeyer et al. 2001) research has demonstrated that glutamine increases intracellular Hsp72 88 
[iHsp72 (epithelial cells)] concentrations, thus it is plausible to suggest that such interventions may 89 
elevate eHsp72 concentrations. Because the release mechanism of Hsp72 into the extracellular 90 
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environment is still not fully defined, it is unknown if interventions that increase iHsp72 also influence 91 
eHsp72 concentrations. 92 
 93 
Previous research has demonstrated exercise duration to be a key modulator of eHsp72 release 94 
(Febbraio et al. 2002; Marshall et al. 2006; Amorim et al. 2008), and therefore ultra-endurance events, 95 
defined as lasting > 6 h (Zaryski et al. 2005), are likely to induce a significant increase in eHsp72 96 
concentration. The MDS (294.4 km, 7 days, 20-50°C) is physiologically challenging given that 97 
competitors must carry food and survival equipment for the duration of the event, with only rationed 98 
water provided each day, subsequently placing competitors at an increased risk of EHS and potentially 99 
EHI throughout the race. Therefore, a nutritional intervention which increases eHsp72 concentration 100 
prior to a multi-day ultra-endurance event, such as the MDS, could alter the associated immune 101 
response patterns in competitors. Whether or not a basal increase in eHsp72 is beneficial or detrimental 102 
in this regard is currently unknown. The additions of probiotics and glutamine have been shown to 103 
induce an increase in Hsp72 concentration in various cultured cell types (Wischmeyer 2002; Petrof et 104 
al. 2004; Tao et al. 2006). However, to our knowledge, no research has yet been conducted in relation 105 
to probiotic supplementation and the eHsp72 response to EHS relative to a multi-day ultra-endurance 106 
event with logistical and nutritional challenges, such as the MDS. Owing to its immuno-stimulatory 107 
actions, a probiotic or glutamine mediated increase in pre-race eHsp72 may influence the immune 108 
response pattern to EHS (MDS). This knowledge is important because any alteration in pro/anti-109 
inflammatory responses to EHS could influence the severity of EHI (Lim and Mackinnon 2006). 110 
Despite previous studies demonstrating a significant increase in iHsp72 through probiotic and 111 
glutamine supplementation (Wischmeyer 2002; Petrof et al. 2004), no research has investigated if this 112 
alters eHsp72 concentrations prior to and following EHS.  113 
 114 
This preliminary study aimed to investigate the effects of chronic (12-weeks) probiotic 115 
supplementation with (PGLn) or without (PRO) glutamine (both commercially available), on the 116 
eHsp72 response pre- and post-MDS completion. Owing to the effects of probiotics and glutamine on 117 
Hsp72 synthesis, it was hypothesised that PRO and PGLn would increase eHsp72 concentrations pre- 118 
MDS in comparison to a control group (CON). Additionally, it was hypothesised that the nutritional 119 
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interventions would reduce the stress and thus the inflammatory response to exercise, marked by a 120 
blunted post-MDS eHsp72 concentration when compared to CON. 121 
 122 
Materials and methods  123 
 124 
Participants 125 
 126 
Male and female entrants (aged 18-60 years) were contacted via email through the UK organiser 127 
(RunUltra UK). Thirty-two MDS 2015 competitors (6 female, 24 male, age 41; range 23-53 years, 128 
height 1.75 ± 0.08 m, body mass 76.89 ± 2.04 kg) met the inclusion criteria and were recruited for this 129 
study. Participants were excluded from taking part if: (1) unable to attend all testing sessions; (2) 130 
outside of desired age range (18 – 60 years); (3) unsatisfactory health-screen questionnaire completion 131 
(i.e. potential history of heart abnormalities, hypertension, heart disease or diabetes); (4) suffering from 132 
any musculo-skeletal injury that may have impaired participation in the study and/or endurance 133 
training; (5) any known blood related disorder; (6) were taking over-the-counter and/or prescribed 134 
medication which may have influenced normal participation (excluding inhalers for exercise-induced 135 
asthma or the contraceptive pill); (7) were consuming any other commercial supplementation which 136 
conflicted the study parameters (i.e. an alternative probiotic) – and were unwilling to refrain from use 137 
of supplementation over the study period; and (8) any participant who was, or had the potential to 138 
become, pregnant during the study. All participants provided written informed consent, were deemed 139 
healthy and able to take part, and verbally confirmed that they were not currently undertaking any 140 
probiotic or glutamine supplementation regime. Participants were instructed to avoid heat 141 
acclimation/acclimatisation training sessions in the 48 h prior to all data collection visits (excluding the 142 
immediate post-race sample). Of the 32 recruited participants, 94% were compliant to this requirement, 143 
with one participant in both the PRO and CON groups undertaking a bout of heat acclimation training 144 
48 h prior to data collection visit 2. Between data collection visit 2 and departure for the MDS, 31.25% 145 
(n = 10) of participants undertook at least one heat training session [PRO: 2 sessions (n = 5), 3 146 
sessions (n = 1); PGLn: 3 sessions (n = 1); CON: 2 sessions (n = 2), 4 sessions (n = 1)]. All 147 
procedures were approved by the Anglia Ruskin University Ethics Committee, and conformed to the 148 
Declaration of Helsinki.  149 
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 150 
Study overview 151 
 152 
Following a randomised independent measures design; participants were assigned to one of three 153 
experimental conditions utilizing commercially available dietary supplements:  154 
 155 
Probiotic capsules (PRO; n = 11): Participants were required to consume one capsule (Bio-156 
Acidophilus Forte, Biocare Ltd., Birmingham, UK) per day for the duration of the 12-week 157 
intervention period. Each multi-strain capsule contained 150 mg.d
-1
 Lactobacillus acidophilus (10 158 
billion CFU.d
-1
, Lactobacillus acidophilus CUL-60 [NCIMB 30157] and 10 billion CFU.d
-1
 159 
Lactobacillus acidophillus CUL-21 [NCIMB 30156]), 16.8 mg.d
-1
 Bifidobacterium bifidum and lactis 160 
(9.5 billion CFU.d
-1
, Bifidobacterium bifidum CUL-20 [NCIMB 30172] and 0.5 billion CFU.d
-1
 161 
Bifidobacterium animalis subspecies lactis CUL-34 [NCIMB 30153]), and 55.8 mg.d
-1
 162 
fructooligosaccharides. 163 
 164 
Probiotic + glutamine powder (PGLn; n = 10): Participants were required to consume 5 g powder (GI 165 
Complex, UK) per day, mixed well in water or food. 2 billion, Lactobacillus acidophilus CUL-60 166 
(NCIMB 30157), 2 billion; Lactobacillus acidophilus CUL-21 (NCIMB 30156); 50 million, 167 
Bifidobacterium bifidum CUL-20 (NCIMB 30172); 0.95 billion, Bifidobacterium animalis subsp. 168 
Lactis CUL-34 (NCIMB 30153); 5 billion, Lactobacillus salivarius CUL61 (NCIMB 30211), each 5 g 169 
dose also contained 0.9 g L-Glutamine.  170 
  171 
Control (CON; n = 9): maintenance of regular diet. 172 
  173 
Apparent daily adherence to intervention and control was self-reported at 100% for all groups. Due to 174 
the nature of the study, blinding of groups was not possible, however, the PGLn group were unaware of 175 
the addition of glutamine to their probiotic supplement. 176 
 177 
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Data was collected at four time points across the duration of the study, which consisted of three 178 
laboratory visits (visits 1, 2, and 4, Anglia Ruskin University, Cambridge) and one field-based data 179 
collection point (visit 3, Ouarzazate, Morocco), as detailed below (Fig. 1a). 180 
 181 
Visit 1 182 
 183 
This baseline data collection took place 12-weeks prior to the MDS. Participants arrived at the 184 
environmentally controlled laboratory (18°C, 35% RH) in a fasted state (minimum 4 h fasted), with 185 
confounding variables of alcohol (Taylor et al. 2010a), caffeine (Lu et al. 2008), generic 186 
supplementation (Hillman et al. 2011) and smoking (Anbarasi et al. 2006) all controlled in line with 187 
previous work in the field (Taylor et al. 2011; Taylor et al. 2012a; Taylor et al. 2012b), self-reported 188 
adherence was confirmed at 100% for all participants. Upon arrival, participants rested in a semi supine 189 
position to provide a venous blood sample via venepuncture from the antecubital fossa for analysis of 190 
eHsp72, followed by the assessment of maximal oxygen uptake [(V O) as shown in Fig. 1b]. 191 
Participants were provided with the appropriate supplementation regime and information upon 192 
departure, and were required to adhere to instructions for the following 12-weeks. 193 
 194 
Visit 2 195 
 196 
Following 12-weeks of supplementation, participants returned to the laboratory and followed the same 197 
procedures as described for visit 1. Participants then departed the UK to undertake the MDS 2015 the 198 
following week. 199 
 200 
Visit 3 201 
 202 
The MDS 2015 took place from 5
th
 – 11
th
 April, and covered a total distance of 249.4 km across the 203 
Sahara Desert, Morocco (maximum temperature 39°C), over 7 days; each stage commenced at 0900h 204 
(Fig. 1a indicates distances for each stage of the MDS phase of the experimental design). The MDS 205 
required competitors to be self sufficient, meaning they were to carry their own food (minimum 2000 206 
Page 7 of 28
https://mc06.manuscriptcentral.com/apnm-pubs
Applied Physiology, Nutrition, and Metabolism
Draft
 8
kcal per day), equipment, and sleeping materials for the duration of the race. Water was rationed to ~ 207 
9.0 – 10.5 L/day per competitor, dependent on the distance of the stage. 208 
 209 
Upon completion of the race, participants boarded coaches and were taken from the Desert back to the 210 
city of Ouarzazate, for post-race data collection (Fig. 1c). A team of trained experimenters collected 211 
post-race venous blood samples; this data collection took place 6 - 8 h post-race completion. 212 
 213 
Visit 4 214 
 215 
Finally, participants attended the sport science laboratories 7 days post-race, whereby venous blood 216 
samples and body composition were measured in line with visits 1 and 2. Participants were not 217 
required to undertake a V O test during the final visit.  218 
 219 
**Please insert Fig. 1a-c here** 220 
 221 
V O Test  222 
 223 
A graded exercise test to maximal exhaustion on a motorized treadmill (Pulsar, HP Cosmos, UK) 224 
began with a 5 min self-paced warm up. Thereafter, speed was increased by 1 km/h
-1
 every 2 min, after 225 
4 stages (8 min) speed remained constant and treadmill incline increased by 1% every 2 min until 226 
volitional exhaustion (Winter et al. 2006). Online breath-by-breath analysis (Metalyser 3B, Cortex, 227 
UK) was used to determine V O . Measures of HR (Polar, FS1, UK) and ratings of perceived 228 
exertion (RPE) were recorded every 2 min to be used as secondary criteria. The V O  was 229 
considered as the highest V O obtained in any 10 s period, and in line with end point criteria guidelines 230 
of the ACSM; which required participants to meet a plateau in V O, plus 2 of the 3 following criteria: a 231 
failure of HR to increase with increasing exercise intensity, respiratory exchange ratio (RER) of > 1.15, 232 
and RPE > 17 (ACSM 2013).   233 
 234 
Blood collection and analysis 235 
 236 
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Venous blood samples were collected at all four visits from the antecubital fossa via venepuncture 237 
(Safety blood collection set and holder, Vacuette®, Greiner Bio-One, UK), directly into three separate 238 
Vacuette® tubes (4 ml; Vacuette® Grenier Bio-One, UK) treated with K3 Ethylenediaminetetraacetic 239 
acid (EDTA) coagulant. Whole blood samples were centrifuged (EBA 200, Hettich, Germany) at 3000 240 
rpm for 10 min for plasma separation, after which the plasma was aliquoted and stored at - 80°C until 241 
analysed in duplicate for eHsp72 using a commercially available high-sensitivity enzyme-linked 242 
immunosorbent assay (ELISA) kit. Whilst the measurement of plasma volume change would have been 243 
beneficial, the applied nature of the study and the logistical challenges present precluded the analysis of 244 
this variable. However, previous research has demonstrated that long-endurance exercise causes no 245 
significant increase in haemoglobin and haematocrit values (Gomez-Merino et al. 2006; Ruell et al. 246 
2006; Suzuki et al. 2006), thus the changes may have been negligible (Suzuki et al. 2000; Suzuki et al. 247 
2003). Incubation of the 96-well kit was performed on an incubital shaker (Heidolph Titramax 1000, 248 
Fischer Scientific, UK) at 500 rpm, and read by a plate reader (VICTOR™ X, Perkin Elmer, UK) using 249 
absorption at 450 nm. Intra-assay variability was 9.93% which was in line with previous work in the 250 
field: Campisi et al. (2003): < 10%; Gibson et al. (2014):  10.5%; Périard et al. (2012): 5%; Walsh et 251 
al. (2001): < 10%; Whitham et al. (2006): 6.3%. 252 
 253 
Statistical analysis 254 
 255 
All statistical analyses were performed using the ‘psych’, ‘nlme’ and ‘stats’ packages in R version 3.3.2 256 
(R Core Development Team, 2014). Normality assumptions were checked using quantile-quantile 257 
plots. Normally distributed data is presented as mean standard deviation (SD), and non-normally 258 
distributed data is presented as median and range. The Akaike information criteria (AIC) was used to 259 
determine fit of the full model relative to the null model (Akaike 1976). A linear mixed model with 260 
fixed (‘condition’, ‘time’) and random (‘subject id’) effects was fitted with a compound symmetric 261 
correlation structure to determine the effect of PRO and PGLn on eHsp72 compared with CON [Time 262 
(4 levels): baseline, pre-race, 6-8 h post-race, 7-d post-race × Condition (3 levels): CON, PRO, PGLn]. 263 
In accordance with previous literature, eHsp72 concentrations were also presented as a percentage 264 
change from baseline, to account for high individual variance in baseline values and responses (Suzuki 265 
et al. 2006; Morton et al. 2007; Sandström et al. 2008; Taylor et al. 2010a; Taylor et al. 2010b; Peart et 266 
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al. 2011; Gibson et al. 2014). The sex of the participants (male or female) was not included as an 267 
independent variable due to the low number of females in the experiment (4 females, 30 males). A one-268 
way analysis of variance (ANOVA) was used to compare time to completion (minutes) between the 269 
CON, PRO, and PGLn groups. The two-tailed alpha level of significance was set as p ≤ 0.05, and 95% 270 
confidence intervals are presented to denote the imprecision in the point estimate.  271 
 272 
Results 273 
 274 
Anthropometric data 275 
  276 
Participant characteristics are displayed in Table 1. For height, those in the PRO group were 5.3 ± 1.5 277 
cm and 6.5 ± 1.6 cm taller than those in the CON and PGLn group, respectively (F2, 125 = 9.372, p < 278 
0.001).  For body mass at baseline, the mass of those in the PGLn group was 8.17 ± 2.46 kg and 8.50 ± 279 
2.57 kg less than those in the PRO and CON group, respectively (F2, 125 = 7.196, p = 0.001). For body 280 
mass at pre-race, the mass of those in the PGLn group was 7.20 ± 2.35 kg and 7.40 ± 2.45 kg less than 281 
those in the PRO and CON group, respectively (F2, 125 = 5.992, p = 0.003). For V O at baseline, 282 
those in the PGLn group had a score 5.33 ± 2.00 ml.kg.min
-1
 greater than those in the CON group (F2, 283 
125 = 3.909, p = 0.023). There were no differences between groups for age and V O at pre-race (p > 284 
0.05). 285 
 286 
eHsp72 287 
 288 
The eHsp72 response was not different between nutritional groups (CON, PRO, PGLn). There was no 289 
main effect for group (F1,2 = 3.252, p = 0.053) or interaction (condition × time) effect (F1,6 = 1.051, p = 290 
0.399) for eHsp72 responses. There was a main effect for time (F1,3 = 22.716, p < 0.001), showing that 291 
eHsp72 was elevated by 0.81 ± 0.36 ng·ml
-1
 (95% CI = 0.20 to 1.43 ng·ml
-1
) at 6-8 h post-race 292 
compared with baseline (p = 0.02). The boxplots in Fig. 2 show the variability in the responses for each 293 
group over time. Table 2 displays the mean ± SD (range) of eHsp72 for each condition at each time 294 
point. Table 3 displays the model’s fixed effects coefficients and random effect variances. Individual 295 
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responses over time are displayed in Fig. 3 a-c, where the change is expressed as a % change from 296 
baseline. 297 
 298 
Time to completion 299 
 300 
The time to completion was not different (F1, 2 = 0.615, p = 0.548) between the CON (2819 ± 846 min, 301 
95% CI = 2213 to 3425 min), PRO (2481 ± 525 min, 95% CI = 2105 to 3424 min), and PGLn (2570 ± 302 
707 min, 95% CI = 2064 to 3075 min) groups. The boxplots in Fig. 4 show the variability in time to 303 
completion for each group. 304 
 305 
** Insert Table 2 near here please ** 306 
**Insert Table 3 near here please**  307 
 308 
** Insert Fig 2, 3 a-c and 4 near here please **  309 
 310 
Discussion 311 
 312 
The primary aim of this study was to investigate the effects of chronic PRO and PGLn commercially 313 
available supplementation on the eHsp72 response to the MDS. The experimental hypothesis was not 314 
accepted in this paper, as PRO and PGLn supplementation had no effect on eHsp72 concentration over 315 
the 12-week supplementation period. In addition, post-MDS eHsp72 concentration was significantly 316 
elevated in all groups, however there was no difference in the magnitude of change in the CON group 317 
compared to PRO or PGLn. These findings indicate that 12-week supplementation with PRO or PGLn 318 
had no influence on eHsp72 concentrations. 319 
 320 
A mean 124% increase in eHsp72 concentration was seen across all conditions post-MDS, compared to 321 
pre-MDS values (Fig. 2a), supporting previous data related to the EHS response (Walsh et al. 2001; 322 
Gomez-Merino et al. 2006; Suzuki et al. 2006; Gibson et al. 2014). The magnitude of this response 323 
post-MDS was not different between groups, indicating that the utilised nutritional intervention had no 324 
influence on pre-MDS eHsp72 concentrations, despite a likely increase in iHsp72 pre-race (Tao et al. 325 
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2006). The novelty of the present study (i.e. MDS exercise model and 12-week nutritional 326 
interventions) renders it challenging to make direct comparisons to previous research. Indeed, to the 327 
author’s knowledge only two previous studies have reported the eHsp72 response to ultra-endurance 328 
exercise performance (Gomez-Merino et al. 2006; Suzuki et al. 2006). These studies demonstrated an 329 
increased eHsp72 concentration of ~ 2200% (Suzuki et al. 2006) and ~ 1674% (Gomez-Merino et al. 330 
2006) following an ironman triathlon and 100 km run, respectively. 331 
 332 
The difference in magnitude of response between the present study (~124% increase) and others 333 
(Gomez-Merino et al. 2006; Suzuki et al. 2006) could be attributed to a number of factors. Firstly, the 334 
logistical issues associated with field-based research, particularly the MDS location, determined that 335 
post-exercise sampling was only feasible 6-8 h post-MDS. It is therefore possible that the greatest 336 
phase of the response was not recorded. Fehrenbach et al. (2005) demonstrated that eHsp72 337 
concentration returned to baseline levels within 24 h of exercise completion, following a marathon run, 338 
with values already significantly different at 3 h post-exercise in comparison to immediately post-339 
exercise. It is therefore likely that the 6-8 h time course between MDS completion and sample 340 
collection in the present study elicited lower eHsp72 concentration changes from pre-race in 341 
comparison to the values that would have been displayed immediately post-race. Future research 342 
should aim to collect data as close to race completion as possible to obtain the most representative 343 
results. 344 
 345 
Secondly, the difference may be due to a habituation effect, given the consecutive and multi-day nature 346 
of the MDS compared to the discrete within one-day ironman triathlon and 100 km run. Following 7 347 
consecutive days of EHS, participants would likely begin to undergo heat acclimatisation, given heat 348 
acclimation/acclimatisation has been shown to commence in as few as 4 exercise-heat exposures 349 
(Petersen et al. 2010), with ‘full’ heat acclimation taking typically 7-14 days (Tyler et al. 2016). Thus, 350 
by the 7
th
 consecutive day of EHS, it is likely that participants would have developed a level of 351 
acclimation to these conditions. Consequently, resting eHsp72 concentration prior to the 352 
commencement of the final MDS stage would potentially have been greater than recorded pre-race 353 
values. For example, Sandström et al. (2008) investigated the effects of 15 consecutive days heat 354 
acclimation on eHsp70, and demonstrated the impact of acclimation upon eHsp70 concentration. In 355 
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that paper, resting eHsp70 following 7 days heat acclimation was 45% greater than baseline 356 
concentration. In addition, the pre- to post-acclimation change on day 1 (54%) showed a greater effect 357 
in comparison to that of day 7 (-4.5%). This speculation could aid understanding regarding the less 358 
substantial increase in eHsp72 post-exercise in comparison to previous ultra-endurance research 359 
(Gomez-Merino et al. 2006; Suzuki et al. 2006). It is possible that the MDS induced a level of 360 
acclimatisation, which subsequently impacted the eHsp72 concentrations recorded following 361 
completion of the race, masking any influence of the probiotic supplement. However, as all participants 362 
completed the race, it is likely that the possible heat acclimatisation stimulus of MDS completion, and 363 
any subsequent confounding effects of such acclimatisation, would have been similar across 364 
participants. Whether within-race heat acclimatisation did mask any potential benefits of the probiotics 365 
cannot be excluded within the present design. Future research is recommended to analyse additional 366 
markers (such as IL-6, TNF- α), in order to obtain a greater understanding regarding the response to 367 
ultra-endurance exercise and probiotic supplementation.  368 
 369 
Previous in vitro research has suggested that a key mechanism behind the protective role of probiotic 370 
(Petrof et al. 2004; Tao et al. 2006) and glutamine (Wischmeyer et al. 2001) is elevations in basal 371 
iHsp72 concentrations. Tao et al. (2006) stated that the induction of iHsp72 following probiotic 372 
treatment in vitro may be due to changes in gene transcription through binding of heat shock factor-1, a 373 
key activator responsible for transcription of heat shock genes (Zuhl et al. 2014). Because the 374 
systematic concentrations of Hsp72 may be proportional to the iHsp72 concentration, it was important 375 
to investigate if probiotic supplementation also influenced eHsp72 concentrations. In contrast to 376 
previous in vitro research (Petrof et al. 2004; Tao et al. 2006), the present study utilised commercially 377 
available supplements, which may have contained additional ingredients and subsequently impacted 378 
the response (Maughan 2005). Future research utilising similar experimental designs should develop a 379 
standardised and pharmacologically optimised probiotic supplement strain (which may likely be 380 
hybridised), to avoid the previously documented lack of quality control of probiotics (Tuomola et al. 381 
2001). It may also be suggested that the prescribed glutamine dosage was insufficient to induce a 382 
significant eHsp72 response in vivo. Previous research has utilised a dosage relative to the individuals’ 383 
body mass (Zuhl et al. 2014; Zuhl et al. 2015), however the present study implemented the suppliers’ 384 
recommended dosage, and subsequently may have been insufficient to induce a significant response. 385 
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Should the present study have implemented the individualised dosages as utilised by Zuhl et al. (2014), 386 
dosages would range from 19.75 – 67.05 g PRO/PGLn supplementation per day (based on fat free mass 387 
range 21.95 – 74.5 kg of participants in the present study). However, only 0.9 g/day was administered 388 
in this study, demonstrating a deviation of 18.85 – 66.15 g/day from the aforementioned dosage (Zuhl 389 
et al. 2014). Evidently, these differences are substantial, and thus the effect of PRO and PGLn from the 390 
dosage utilised in the present study may have been insufficient to induce a significant response. It is 391 
important to note, however, that competitors would have utilised the commercially available dietary 392 
supplements in the same manner (i.e. in line with the supplier recommendations) as the design 393 
employed by the present study. Another consideration is the makeup of the probiotic supplement. 394 
Whilst there are limited studies in this area (particularly using the specific strains supplied in the 395 
present study), the predominance of Lactobacillus and Bifidobacterium bifidum species in this 396 
supplement indicate that these would have the strongest influence upon the eHsp72 response (if any). 397 
Although the lactobacillus and Bifidobacterium strains activate the innate immune system (Bellavia et 398 
al. 2013; Lescheid 2014), it is unclear what specific strains interact with eHsp72. Additionally, whilst 399 
there was a level of prebiotic included within the supplement, this very small dosage (55.8 mg.d-1 400 
fructooligosaccharides; FOS) is unlikely to have had an effect on eHsp72 concentration.  401 
 402 
It is evident that participation in a multi-day ultra-endurance event imposes a significant level of stress 403 
upon the human body, leading to an increase in eHsp72 concentration. Such increases are likely for 404 
stimulation of pro-inflammatory cytokine and chemokines, which is typical during EHS. However, the 405 
implementation of commercially available PRO and PGLn supplementation, in line with supplier 406 
recommendations, did not increase basal eHsp72 concentration prior to the race, or alter the eHsp72 407 
response seen in all groups post-race.  408 
 409 
Experimental limitations, practical applications and future research directions 410 
 411 
Collection of data within an applied setting involves a number of challenges, particularly when in a 412 
harsh environment, such as the Sahara Desert. Due to methodological limitations in the present work, it 413 
is recommended that future research collect samples immediately / within 1 h of race completion, and 414 
should implement a dosage relative to the body mass of the individual taking part, in addition to 415 
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utilising robustly standardised and optimised nutritional supplements. This will confirm if PRO or 416 
PGLn increases basal eHsp72 values prior to ultra-endurance events, particularly those completed 417 
within thermally challenging environments. Additionally, future research should focus on controlling 418 
the outlined confounding variables alongside analysis of additional biological markers, such as 419 
inflammatory markers (IL-6, TNF- α), intracellular markers (iHsp72), and markers of endotoxemia/gut 420 
damage (LPS); to greater understand the implicated biological cascades such as gut damage. To 421 
increase internal validity within similar research designs, all participants should complete the exact 422 
same robust heat acclimation regime (or completely avoid any acclimation) prior to leaving for the 423 
MDS, to control the potential confounding influence of heat acclimation/acclimatisation upon eHsp72 424 
concentrations pre and during race. Therefore, whilst the presented results should be interpreted 425 
carefully relative to these limitations, the findings remain relevant to athletes and coaches, given we 426 
have shown that the specific commercially available probiotic supplements and chronic administration 427 
strategies utilised are unlikely to interfere with the pathways regulating immune responses to multi-day 428 
ultra-endurance running exercise in the heat.  429 
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Table 1. Anthropometrical characteristics of age, height, mass; body fat percentage, and V O data 627 
(week 1 and week 12) are reported as means ± SD (age is reported as range due to non-normal 628 
distribution). 629 
 630 
 631 
 632 
 633 
 634 
Table 2. Mean ± SD (range) eHsp72 (ng.ml-1) concentration between groups at each data collection 635 
time point. 636 
 637 
Kg: kilograms; 
 : maximal volume of oxygen consumption; ml.kg.min
-1
: millilitres per 638 
kilogram per minute. PRO: Probiotic; PGLn: Probiotic + Glutamine; CON: Control 639 
 640 
 641 
 642 
 643 
 644 
 645 
  
 
Baseline Pre-race 
Group Age 
(years) 
Mass 
(Kg) 

  
(ml.kg.min
-1
) 
 Mass  
(Kg) 

  
(ml.kg.min
-1
) 
PRO 25 – 50  78.87 ± 6.93 56.42 ± 8.26  77.49 ± 6.52 59.40 ± 6.33 
PGLn 31 – 53 71.34 ± 12.92 56.50 ± 5.95  70.09 ± 12.31 59.25 ± 6.92 
CON 23 – 60  79.50 ± 14.07 51.17 ± 12.68  77.29 ± 12.92 55.25 ± 11.96 
Group Baseline Pre-race 6 hours post race 7 d post-race 
CON 1.68 ± 1.65 
(0.59 – 3.81) 
1.82 ± 1.98 
(0.63 – 1.93) 
3.45 ± 3.35 
(0.78 – 3.30) 
2.05 ± 2.49 
(0.67 – 2.17) 
PRO 1.20 ± 0.58 
(0.68 – 2.70) 
1.58 ± 0.87 
(0.75 – 2.96) 
2.77 ± 1.21 
(1.82 – 7.30) 
1.80 ± 1.27 
(0.82 – 4.13) 
PGLn 1.77 ± 2.51 
(0.59 – 1.90) 
1.03 ± 0.45 
(0.73 – 2.19) 
2.20 ± 0.76 
(1.57 – 4.16) 
1.04 ± 0.41 
(0.71 – 2.16) 
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Table 3. Beta coefficients (B), 95 % confidence intervals (CI), and alpha values (p) are reported for the 646 
fixed components (Supplement & time) before and after the MDS race. The standard deviation of the 647 
intercept and residual are reported for the random effect (subject ID). 648 
 649 
  eHsp72 (ng.ml
-1
) 
  B 95% CI p 
Fixed Parts 
(Intercept) 1.31 0.79 – 1.83 <.001 
Condition Effect       
PRO 0.02 -0.72 – 0.75 0.968 
PGLn -0.32 -1.09 – 0.45 0.421 
Time Effect       
Pre-Race -0.1 -0.70 – 0.50 0.742 
6-8 h Post-Race 0.81 0.20 – 1.43 0.011 
1-Week Post-Race -0.04 -0.67 – 0.60 0.911 
Condition: Time Interaction       
PRO: Pre-Race 0.27 -0.59 – 1.13 0.541 
PGLn: Pre-Race 0.13 -0.75 – 1.01 0.770 
PRO: 6-8 h Post-Race 1.01 0.15 – 1.87 0.023 
PGLn: 6-8 h Post-Race 0.38 -0.51 – 1.28 0.401 
PRO: 1-Week Post-Race 0.6 -0.31 – 1.50 0.198 
PGLn: 1-Week Post-Race 0.09 -0.82 – 1.00 0.851 
Random Parts 
σ2 0.511 
τ00, ID 0.258 
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Figure legends  673 
 674 
Fig. 1 a-c Experimental schematic outlining: a: the full experimental study design, b: procedures of 675 
Visits 1, 2 and 4, c: procedure of Visit 3  676 
 677 
Fig. 2 Boxplots showing the variability in responses for each group over time. #Denotes a significant 678 
effect of time on eHsp72 concentration 679 
  680 
Fig. 3 a-c Individual eHsp72 responses within groups, as a % change from baseline (a: PRO, b: PGLn, 681 
c: CON) 682 
 683 
Fig. 4 Boxplots showing the variability in time to completion for each group  684 
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Fig. 1 a-c Experimental schematic outlining: a: the full experimental study design, b: procedures of Visits 1, 
2 and 4, c: procedure of Visit 3  
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Fig. 2 Boxplots showing the variability in responses for each group over time. #Denotes a significant effect 
of time on eHsp72 concentration  
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Fig. 3 a-c Individual eHsp72 responses within groups, as a % change from baseline (a: PRO, b: PGLn, c: 
CON)  
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Fig. 4 Boxplots showing the variability in time to completion for each group  
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